These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1555964)

  • 1. A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources.
    Meigooni AS; Nath R
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1125-30. PubMed ID: 1555964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial dose functions for 103Pd, 125I, 169Yb and 192Ir brachytherapy sources: an EGS4 Monte Carlo study.
    Mainegra E; Capote R; López E
    Phys Med Biol; 2000 Mar; 45(3):703-17. PubMed ID: 10730965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APPLICABILITY OF PURE PROPANE GAS FOR MICRODOSIMETRY AT BRACHYTHERAPY ENERGIES: A FLUKA STUDY.
    Chattaraj A; Selvam TP
    Radiat Prot Dosimetry; 2020 Jul; 189(3):286-293. PubMed ID: 32259843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources.
    Wuu CS; Kliauga P; Zaider M; Amols HI
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):689-97. PubMed ID: 8948355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
    Mainegra E; Capote R; López E
    Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose rate distributions around 60Co, 137Cs, 198Au, 192Ir, 241Am, 125I (models 6702 and 6711) brachytherapy sources and the nuclide 99Tcm.
    Sakelliou L; Sakellariou K; Sarigiannis K; Angelopoulos A; Perris A; Zarris G
    Phys Med Biol; 1992 Oct; 37(10):1859-72. PubMed ID: 1438552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of high-energy brachytherapy source electronic disequilibrium and dose from emitted electrons.
    Ballester F; Granero D; Pérez-Calatayud J; Melhus CS; Rivard MJ
    Med Phys; 2009 Sep; 36(9):4250-6. PubMed ID: 19810499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ytterbium-169: a promising new radionuclide for intravascular brachytherapy.
    Patel NS; Fan P; Chiu-Tsao ST; Ravi K; Sherman W; Quon H; Pisch J; Tsao HS; Harrison LB
    Cardiovasc Radiat Med; 2001; 2(3):173-80. PubMed ID: 11786324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More accurate fitting of 125I and 103Pd radial dose functions.
    Taylor RE; Rogers DW
    Med Phys; 2008 Sep; 35(9):4242-50. PubMed ID: 18841874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1239-50. PubMed ID: 8985050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
    Nath R; Meigooni AS; Melillo A
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass attenuation coefficients of clear-Pb for photons from 125I, 103Pd, 99mTc, 192Ir, 137Cs and 60Co.
    Rivard MJ; Waid DS; Wierzbicki JG
    Health Phys; 1999 Nov; 77(5):571-8. PubMed ID: 10524511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
    Williamson JF; Perera H; Li Z; Lutz WR
    Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the depth of penetration of photons and electrons for intravascular brachytherapy.
    Nath R; Yue N; Liu L
    Cardiovasc Radiat Med; 1999; 1(1):72-9. PubMed ID: 11272359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.